Analysis of HBV-DNA in Hepatitis B Patients with HBeAg Negative in JiLin Area

Abstract:

Objective: To illustrate the relationship between serum HBV-M and HBV-DNA in HBeAg-negative HBV patients. Methods: Serum isolated from HBV patients. FQ-PCR was used to detect the levels of HBV-DNA. ELISA was used to detect the serum HBV-M. Results: The positive rate of HBV-DNA was much higher in HBeAg-positive HBV patients (98.6%) than in HBeAg-negative HBV patients (48.7%). Among the different HBV-M patterns, the positive rate of HBV-DNA with positive HBsAg, HBeAb, and HBcAb was 59.4%; the positive rate of HBV-DNA with positive HBsAg and HBcAb was 32.3%; the positive rate of HBV-DNA with positive HBsAb, HBeAb, and HBcAb was 30.4%; the positive rate of HBV-DNA with positive HbeAb and HBcAb was 13.6%; the positive rate of HBV-DNA with positive HBcAb was 7.7%; the positive rate of HBV-DNA with positive HBsAb and HBcAb was 33.3%. Conclusion: HBV-DNA does still replicate in HBeAg negative HBV patients, and copies of HBV-DNA is a sensitive monitoring marker of monitoring HBV replication for those persons infected HBV.

• Periodical: Advanced Materials Research (Volumes 850-851)
• Pages: 1212-1215
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.850-851.1212
• Online since: December 2013
• Authors: Chen Zhao*, Yang Zhao, Zhong Hai Yuan, Yi Ju Hou, Xiao Ming Jiang, Yan Li
• Keywords: HBeAg, HBV-DNA, HBV-M, Hepatitis B

References

[1] Shunichi Sato, Kazuyuki Suzuki, Yoshihiro Akahane, et al. Hepatitis B Virus Strains with Mutations in the Core Promoter in Patients with Fulminant Hepatitis. Ann Intern Med. 1995; 122(4): 241-248.

DOI: 10.7326/0003-4819-122-4-199502150-00001

[2] Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006 Jan 4; 295 (1): 65-73.

DOI: 10.1001/jama.295.1.65

[3] Ding Liu, Liu Li, Lei Xue-Zhong, et al. Comparation of HBV-DNA and HBVm in serum of 5600 patients. J Sichuan Univ. 2006; 37( 2) : 313-314.

[4] Malmström S, Larsson SB, Hannoun C, et al. Hepatitis B Viral DNA Decline at Loss of HBeAg Is Mainly Explained by Reduced cccDNA Load–Down-Regulated Transcription of PgRNA Has Limited Impact. PLoS One. 2012; 7 (7): e36349.

DOI: 10.1371/journal.pone.0036349

[5] Thompson AJ, Nguyen T, Iser D, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology. 2010 Jun; 51 (6): 1933-(1944).

DOI: 10.1002/hep.23571

[6] Nguyen T, Thompson AJ, Bowden S, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol. 2010 Apr; 52 (4): 508-513.

DOI: 10.1016/j.jhep.2010.01.007

[7] McLachlan A, Milich DR, Raney AK, et al. Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol. 1987 Mar; 61 (3): 683-692.

DOI: 10.1128/jvi.61.3.683-692.1987

[8] Bruss V, Gerlich WH. Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein. Virology. 1988 Apr; 163 (2): 268-275.

DOI: 10.1016/0042-6822(88)90266-8

[9] Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989 Sep 9; 2 (8663): 588-591.

DOI: 10.1016/s0140-6736(89)90713-7

[10] Okamoto H, Yotsumoto S, Akahane Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol. 1990 Mar; 64 (3): 1298-303.

DOI: 10.1128/jvi.64.3.1298-1303.1990

[11] Myers RM, Tilly K, Maniatis T. Fine structure genetic analysis of beta-globin promoter. Science. 1986 May 2; 232 (4750): 613-618.

DOI: 10.1126/science.3457470

[12] White RJ, Jackson SP. The TATA-binding protein: a central role in transcription by RNA polymerases I, II, and III. Trends Genet. 1992 Aug; 8 (8): 284-288.

DOI: 10.1016/0168-9525(92)90255-3